A review on the role of NCK1 Antisense RNA 1 (NCK1-AS1) in diverse disorders.
暂无分享,去创建一个
[1] M. Taheri,et al. A long non-coding RNA with important roles in the carcinogenesis , 2022, Frontiers in Cell and Developmental Biology.
[2] S. Ghafouri-Fard,et al. Identification of expression of CCND1-related lncRNAs in breast cancer. , 2022, Pathology, research and practice.
[3] Kui-Sheng Chen,et al. Long non-coding RNA NCK1-AS1 is overexpressed in esophageal squamous cell carcinoma and predicts survival , 2022, Bioengineered.
[4] Yuanshuai Huang,et al. LncRNA NCK1-AS1 Aggravates Hepatocellular Carcinoma by the miR-22-3p/YARS Axis to Activate PI3K/AKT Signaling. , 2022, Journal of gastrointestinal and liver diseases : JGLD.
[5] D. Gu,et al. LncRNA NCK1-AS1 Promotes Malignant Cellular Phenotypes of Laryngeal Squamous Cell Carcinoma via miR-137/NCK1 Axis , 2022, Molecular Biotechnology.
[6] Juncheng Wang,et al. Knockdown of NCK1-AS1 inhibits the development of atherosclerosis by targeting miR-1197/COX10 axis , 2022, Journal of biological engineering.
[7] M. Taheri,et al. Bioinformatics analysis of long non-coding RNA-associated competing endogenous RNA network in schizophrenia , 2021, Scientific Reports.
[8] S. Teimourian,et al. An updated review of the role of lncRNAs and their contribution in various molecular subtypes of breast cancer , 2021, Expert review of molecular diagnostics.
[9] Q. Lin,et al. NCK1-AS1 promotes the progression of melanoma by accelerating cell proliferation and migration via targeting miR-526b-5p/ADAM15 axis , 2021, Cancer cell international.
[10] X. Zhuang,et al. AS1 expression in prostate cancer and its effects on proliferation and invasion of prostate cancer cells. , 2021, Cancer biomarkers : section A of Disease markers.
[11] Jun Ma,et al. LncRNA NCK1‐AS1 exerts oncogenic property in gastric cancer by targeting the miR‐22‐3p/BCL9 axis to activate the Wnt/β‐catenin signaling , 2021, Environmental toxicology.
[12] Danhong Zhang,et al. NCK1-AS1 promotes the progression of lung squamous cell carcinoma through transcriptionally upregulating NCK1 via interacting with MYC , 2021, Cancer biology & therapy.
[13] Huiming Pan,et al. Upregulation of lncRNA NCK1-AS1 predicts poor prognosis and contributes to non-small cell lung cancer proliferation by regulating CDK1. , 2021, European Review for Medical and Pharmacological Sciences.
[14] Maite Huarte,et al. Gene regulation by long non-coding RNAs and its biological functions , 2020, Nature reviews. Molecular cell biology.
[15] M. Taheri,et al. The Role of Non-Coding RNAs in Controlling Cell Cycle Related Proteins in Cancer Cells , 2020, Frontiers in Oncology.
[16] P. Luo,et al. LncRNA NCK1-AS1 in plasma distinguishes oral ulcer from early-stage oral squamous cell carcinoma , 2020, Journal of biological research.
[17] Jianqiang Zhao,et al. Long non-coding RNA NCK1-AS1 promotes the proliferation, migration and invasion of non-small cell lung cancer cells by acting as a ceRNA of miR-137. , 2020, American journal of translational research.
[18] Pin Lv,et al. Long Non-Coding RNA NCK1-AS1 Serves an Oncogenic Role in Gastric Cancer by Regulating miR-137/NUP43 Axis , 2020, OncoTargets and therapy.
[19] Qiling Xu,et al. NCK1-AS1 enhances glioma cell proliferation, radioresistance and chemoresistance via miR-22-3p/IGF1R ceRNA pathway. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[20] Peng Huang,et al. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis. , 2020, Pathology, research and practice.
[21] M. Taheri,et al. Non-coding RNAs are involved in the response to oxidative stress. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[22] Chao Yang,et al. Long non-coding RNA NCK1-AS1 promotes the tumorigenesis of glioma through sponging microRNA-138-2-3p and activating the TRIM24/Wnt/β-catenin axis , 2020, Journal of Experimental & Clinical Cancer Research.
[23] Qiang Li,et al. LncRNA NCK1-AS1 Promotes Cancer Cell Proliferation and Increase Cell Stemness in Urinary Bladder Cancer Patients by Downregulating miR-143 , 2020, Cancer management and research.
[24] Haili Hu,et al. Downregulation of lncRNA NCK1-AS1 Inhibits Cancer Cell Migration and Invasion in Nasopharyngeal Carcinoma by Upregulating miR-135a , 2019, Cancer management and research.
[25] Yi Cheng,et al. Knockdown Of lncRNA NCK-AS1 Regulates Cisplatin Resistance Through Modulating miR-137 In Osteosarcoma Cells , 2019, OncoTargets and therapy.
[26] Hua Chang,et al. NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer. , 2019, Biochemical and biophysical research communications.
[27] Haikang Zhao,et al. NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/TRIM24. , 2019, Cancer biotherapy & radiopharmaceuticals.
[28] J. Pu,et al. Altered expression of lncRNA NCK1-AS1 distinguished patients with prostate cancer from those with benign prostatic hyperplasia , 2019, Oncology letters.
[29] Ying-bin Wang,et al. Upregulation of lncRNA RMRP promotes the activation of cardiac fibroblasts by regulating miR-613 , 2019, Molecular medicine reports.
[30] Ping Chen,et al. Suppression of long noncoding RNA NCK1‐AS1 increases chemosensitivity to cisplatin in cervical cancer , 2018, Journal of cellular physiology.
[31] Fangzhou Song,et al. LncRNA NCK1-AS1 promotes proliferation and induces cell cycle progression by crosstalk NCK1-AS1/miR-6857/CDK1 pathway , 2018, Cell Death & Disease.
[32] Yanxin Li,et al. TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma , 2017, Nature Communications.
[33] S. Ghafouri-Fard,et al. Long Non Coding RNA Expression Intersecting Cancer and Spermatogenesis: A Systematic Review , 2017, Asian Pacific journal of cancer prevention : APJCP.
[34] David G. Knowles,et al. The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression , 2012, Genome research.